SAN FRANCISCO, June 02, 2022 (GLOBE NEWSWIRE) — Hagens Berman urges Enochian Biosciences, Inc. (NASDAQ: ENOB) investors with significant losses to submit your transactions now. The firm is investigating possible securities law violations.
Visit: www.hbsslaw.com/investor-fraud/ENOB
Contact An Attorney Now: ENOB@hbsslaw.com
844-916-0895
Enochian Biosciences, Inc. (ENOB) Investigation:
Specifically, the investigation focuses on Enochian’s repeated assurances that “[m]any of the techniques utilized in the development of our product candidates have been developed by Dr. Serhat Gumrukcu,” whom the company needs to retain to achieve its research, development, regulatory approvals and commercialization objectives.
Enochian’s claimed need for Gumrukcu and the utility of his “techniques” came into serious question beginning on May 25, 2022, when the U.S. Attorney for the District of Vermont announced Gumrukcu was arrested after having been charged by a federal grand jury with conspiring to use interstate commerce in the commission of murder-for-hire. According to the U.S. Attorney’s office, the murder of Gregory Davis was potentially motivated by Davis’ threat to inform the FBI that Gumrukcu and his brother were defrauding Davis in a multi-million-dollar oil deal.
Then, on June 1, 2022, Hindenburg Research published a scathing report entitled “Miracle Cures and Murder-For-Hire: How…
